Ella Ioffe
Impact in
- Ophthalmology top 1%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Angiogenesis and VEGF in Cancer 8
- Oncology 13
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 5
- Co-authors
- George D. Yancopoulos (10 shared papers)John S. Rudge (8 shared papers)Susan D. Croll (2 shared papers)Jocelyn Holash (2 shared papers)Elena Burova (10 shared papers)Gavin Thurston (10 shared papers)Donald M. McDonald (2 shared papers)Nicole L. Glazer (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (5 papers)Cancer Research (3 papers)Cancer Immunology Research (2 papers)Molecular Cancer Therapeutics (1 paper)Nature Medicine (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Ella Ioffe
23 papers receiving 3.5k citations
Ella Ioffe's Hit Papers
Peers
Comparison fields: 5 of 105
- Ophthalmology 577
- Cancer Research 643
- Molecular Biology 2.3k
- Oncology 768
- Immunology and Allergy 156
Countries citing papers authored by Ella Ioffe
This map shows the geographic impact of Ella Ioffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Ioffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Ioffe more than expected).
Fields of papers citing papers by Ella Ioffe
This network shows the impact of papers produced by Ella Ioffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Ioffe. The network helps show where Ella Ioffe may publish in the future.
Co-authors
The 25 scholars most cited alongside Ella Ioffe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | VEGF-Trap: A VEGF blocker with potent antitumor effects Hit paper breakdown → | 2002 | 1325 |
| 2 | Angiopoietin-1 protects the adult vasculature against plasma leakage Hit paper breakdown → | 2000 | 1055 |
| 3 | 2004 | 261 | |
| 4 | 2006 | 203 | |
| 5 | 2002 | 164 | |
| 6 | 1998 | 89 | |
| 7 | 2006 | 84 | |
| 8 | 2005 | 80 | |
| 9 | 1995 | 75 | |
| 10 | 2019 | 62 | |
| 11 | 1998 | 55 | |
| 12 | 2008 | 52 | |
| 13 | 2016 | 47 | |
| 14 | 1997 | 30 | |
| 15 | 1996 | 24 | |
| 16 | 2005 | 16 | |
| 17 | 2023 | 8 | |
| 18 | 2025 | 2 | |
| 19 | 2014 | 2 | |
| 20 | Inhibition of IL-1 Blocks Corneal Inflammation and Neovascularization | 2003 | 1 |
About Ella Ioffe
Ella Ioffe is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 24 papers that have together received 3.6k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (5 papers), Lipid metabolism and disorders (4 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Pancreatic function and diabetes (2 papers) and Biochemical Analysis and Sensing Techniques (2 papers). The work is most often cited by research in Ophthalmology (577 citations), Cancer Research (643 citations), Molecular Biology (2.3k citations), Oncology (768 citations) and Immunology and Allergy (156 citations). Ella Ioffe has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include George D. Yancopoulos, John S. Rudge, Susan D. Croll, Jocelyn Holash, Elena Burova, Gavin Thurston, Donald M. McDonald, Nicole L. Glazer, Leorah Ross and James P. Fandl. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research, Cancer Immunology Research, Molecular Cancer Therapeutics and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.